Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $228,559 (100.0% shares, 0.0% debt)

Holdings (38)

CI CIGNA CORP NEW 9.7%
Value ($000) $22,193 Shares 138,000 Est. Cost $179.63 Unrealized -7.0%
HANGER INC 7.8%
Value ($000) $17,784 Shares 933,548 Est. Cost $20.83 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 6.9%
Value ($000) $15,771 Shares 123,500 Est. Cost $109.33 Unrealized -1.7%
REATA PHARMACEUTICALS INC 6.6%
Value ($000) $15,017 Shares 175,700 Est. Cost $46.26 Unrealized
BMY BRISTOL MYERS SQUIBB CO 5.9%
Value ($000) $13,502 Shares 283,000 Est. Cost $38.30 Unrealized 0.0%
ARENA PHARMACEUTICALS INC 5.0%
Value ($000) $11,320 Shares 252,500 Est. Cost $42.17 Unrealized
WELLCARE HEALTH PLANS INC 4.8%
Value ($000) $10,979 Shares 40,700 Est. Cost $236.10 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 3.8%
Value ($000) $8,721 Shares 917,080 Est. Cost $11.58 Unrealized -16.1%
ALBIREO PHARMA INC 3.8%
Value ($000) $8,691 Shares 269,836 Est. Cost $29.61 Unrealized
NEVRO CORP 3.5%
Value ($000) $8,049 Shares 128,765 Est. Cost $62.51 Unrealized
ASGN ASGN INC 3.0%
Value ($000) $6,928 Shares 109,116 Est. Cost $64.66 Unrealized -3.3%
ASSEMBLY BIOSCIENCES INC 2.7%
Value ($000) $6,191 Shares 314,410 Est. Cost $28.21 Unrealized
CLOVIS ONCOLOGY INC 2.7%
Value ($000) $6,190 Shares 249,389 Est. Cost $23.17 Unrealized
URGN UROGEN PHARMA LTD 2.6%
Value ($000) $5,831 Shares 157,862 Est. Cost $41.92 Unrealized 0.0%
ALDX ALDEYRA THERAPEUTICS INC 2.3%
Value ($000) $5,267 Shares 583,300 Est. Cost $9.71 Unrealized -12.5%
BMRN BIOMARIN PHARMACEUTICAL INC 2.2%
Value ($000) $5,097 Shares 57,384 Est. Cost $91.65 Unrealized +1.1%
EXACT SCIENCES CORP 2.1%
Value ($000) $4,721 Shares 54,500 Est. Cost Unrealized
STRONGBRIDGE BIOPHARMA PLC 2.0%
Value ($000) $4,651 Shares 933,876 Est. Cost $4.65 Unrealized
WAGEWORKS INC 1.9%
Value ($000) $4,377 Shares 115,926 Est. Cost $37.76 Unrealized
NEVRO CORP 1.9%
Value ($000) $4,375 Shares 70,000 Est. Cost Unrealized
SIERRA ONCOLOGY INC 1.8%
Value ($000) $4,203 Shares 2,457,683 Est. Cost $1.95 Unrealized
CNC CENTENE CORP DEL 1.8%
Value ($000) $4,163 Shares 78,400 Est. Cost $60.41 Unrealized +0.5%
MILLENDO THERAPEUTICS INC 1.8%
Value ($000) $4,061 Shares 270,762 Est. Cost $8.31 Unrealized
INTEC PHARMA LTD JERUSALEM 1.7%
Value ($000) $3,980 Shares 542,919 Est. Cost $4.60 Unrealized
CATALYST BIOSCIENCES INC 1.7%
Value ($000) $3,927 Shares 484,200 Est. Cost $9.31 Unrealized
ACIU AC IMMUNE SA 1.6%
Value ($000) $3,588 Shares 710,541 Est. Cost $6.36 Unrealized 0.0%
TELIGENT INC NEW 1.5%
Value ($000) $3,528 Shares 3,041,568 Est. Cost $3.21 Unrealized
PROVIDENCE SVC CORP 1.5%
Value ($000) $3,486 Shares 52,324 Est. Cost $67.28 Unrealized
KURA KURA ONCOLOGY INC 1.3%
Value ($000) $2,868 Shares 172,894 Est. Cost $16.20 Unrealized -4.9%
MGNX MACROGENICS INC 0.8%
Value ($000) $1,934 Shares 107,560 Est. Cost $19.75 Unrealized -12.5%
MOLECULAR TEMPLATES INC 0.8%
Value ($000) $1,730 Shares 297,790 Est. Cost $5.81 Unrealized
MGTX MEIRAGTX HOLDINGS PLC 0.7%
Value ($000) $1,573 Shares 91,317 Est. Cost $14.09 Unrealized 0.0%
ALDEYRA THERAPEUTICS INC 0.6%
Value ($000) $1,466 Shares 162,300 Est. Cost Unrealized
UROV UROVANT SCIENCES LTD 0.4%
Value ($000) $1,004 Shares 99,870 Est. Cost $10.05 Unrealized
CERECOR INC 0.3%
Value ($000) $665 Shares 113,835 Est. Cost $3.23 Unrealized
CIDARA THERAPEUTICS INC 0.3%
Value ($000) $584 Shares 220,264 Est. Cost $6.80 Unrealized
AQUINOX PHARMACEUTICALS INC 0.0%
Value ($000) $76 Shares 28,300 Est. Cost $2.50 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.0%
Value ($000) $68 Shares 709 Est. Cost $89.70 Unrealized 0.0%